Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatitc differentiated thyroid cancer

B. de Keizer; A. Hoekstra; M.W. Konijnenberg; F. de Vos; B. Lambert; P.P. van Rijk; C.J.M. Lips; J.M.H. de Klerk

Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatitc differentiated thyroid cancer

Translated title of the contribution: Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatitc differentiated thyroid cancer

B. de Keizer, A. Hoekstra, M.W. Konijnenberg, F. de Vos, B. Lambert, P.P. van Rijk, C.J.M. Lips, J.M.H. de Klerk

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatitc differentiated thyroid cancer
Original language	Undefined/Unknown
Pages (from-to)	1549-1554
Number of pages	6
Journal	Journal of Nuclear Medicine
Volume	45
Issue number	9
Publication status	Published - 2004

Cite this

@article{f208b16b4baa4663b18b9010e45507c1,

title = "Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatitc differentiated thyroid cancer",

author = "{de Keizer}, B. and A. Hoekstra and M.W. Konijnenberg and {de Vos}, F. and B. Lambert and {van Rijk}, P.P. and C.J.M. Lips and {de Klerk}, J.M.H.",

year = "2004",

language = "Undefined/Unknown",

volume = "45",

pages = "1549--1554",

journal = "Journal of Nuclear Medicine",

issn = "0161-5505",

publisher = "Society of Nuclear Medicine Inc.",

number = "9",

}

Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatitc differentiated thyroid cancer. / de Keizer, B.; Hoekstra, A.; Konijnenberg, M.W. et al.
In: Journal of Nuclear Medicine, Vol. 45, No. 9, 2004, p. 1549-1554.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatitc differentiated thyroid cancer

AU - de Keizer, B.

AU - Hoekstra, A.

AU - Konijnenberg, M.W.

AU - de Vos, F.

AU - Lambert, B.

AU - van Rijk, P.P.

AU - Lips, C.J.M.

AU - de Klerk, J.M.H.

PY - 2004

Y1 - 2004

UR - https://www.ncbi.nlm.nih.gov/pubmed/15347723

M3 - Article

SN - 0161-5505

VL - 45

SP - 1549

EP - 1554

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

IS - 9

ER -

Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatitc differentiated thyroid cancer

Other files and links

Cite this